May 3, 2021
Via EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F. Street, N.E. Washington, D.C. 20549 Attention: Abby Adams | |
| Re: | Chembio Diagnostics, Inc. Registration Statement on Form S-3 Filed March 15, 2021 File No. 333-254261 Request for Acceleration |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Chembio Diagnostics, Inc. (the “Registrant”) hereby requests acceleration of the effective date of the above-referenced Registration Statement on Form S-3 (File No. 333-254261) (the “Registration Statement”), so that it may become effective at 5:00 p.m. Eastern time on May 5, 2021, or as soon thereafter as practicable.
Please do not hesitate to contact our legal counsel, Mark L. Johnson, at (617) 261-3260, if you have any questions or would like additional information regarding this matter.
* * *
| | Sincerely, |
| | |
| | Chembio Diagnostics, Inc. |
| | | |
| | By: | /s/Neil A. Goldman | |
| | | Neil A. Goldman |
| | | Executive Vice President, Chief Financial Officer |
cc: | Mark L. Johnson, K&L Gates LLP Bella Zaslavsky, K&L Gates LLP |
